Exhaled volatile organic compounds as novel biomarkers for early detection of COPD, asthma, and PRISm: a cross-sectional study

Abstract

VOC panel-based classification models have the potential to be a novel strategy for the discrimination of chronic respiratory diseases. Using the portal micro gas chromatography enables swift detection of chronic respiratory disease and, most importantly, facilitates the rapid identification of PRISm individuals within the population.